Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Alkermes
Alkermes
Alkermes Outlook Remains Bleak
Yahoo/Zacks.com
Tue, 05/26/09 - 11:06 am
Alkermes
Alkermes: Risperdal Consta gets expanded approval
Yahoo/AP
Mon, 05/18/09 - 11:29 am
Alkermes
Risperdal Consta
FDA
bipolar disorder
FDA Calendar Updates: Amylin, Alkermes, Eli Lilly, Cell Therapeutics
Seeking Alpha
Wed, 05/6/09 - 07:17 am
Cell Therapeutics
Eli Lilly
FDA
Alkermes
Amylin
Amylin, Alkermes rally on FDA filing
Marketwatch
Tue, 05/5/09 - 10:33 am
Amylin
Alkermes
FDA
FDA, Clinical Trial Calendar Updates: Acorda, Alkermes, GTx
Seeking Alpha
Thu, 04/23/09 - 10:05 am
FDA
drug trials
Acorda Therapeutics
GTx
Alkermes
Reworking the Broken R&D Model
Motley Fool
Wed, 04/22/09 - 07:15 am
R&D
GSK
Merck
Isis Pharmaceuticals
Alnylam
Bristol-Myers Squibb
Gilead Sciences
Pfizer
Alkermes
Amylin
Which Diabetes Drugs Will Win Out?
Seeking Alpha
Thu, 04/2/09 - 06:14 am
diabetes
Alkermes
Eli Lilly
Amylin
AstraZeneca
Bristol-Myers Squibb
GSK
Takeda
Merck
Novo Nordisk
Amylin, Novo Nordisk buck downward trend
Marketwatch
Wed, 04/1/09 - 03:51 pm
Amylin
Novo Nordisk
Celgene
Eli Lilly
Alkermes
AstraZeneca
Pharma's Big Drug Test
CNBC
Wed, 04/1/09 - 06:17 am
Merck
GSK
Alkermes
Eli Lilly
Amylin
AstraZeneca
Bristol-Myers Squibb
Bristol-Myers, Novo Nordisk diabetes drugs face FDA review, while Amylin preps for application
Yahoo/AP
Thu, 03/26/09 - 02:47 pm
Bristol-Myers Squibb
Novo Nordisk
FDA
Amylin
Alkermes
saxagliptin
Byetta
Alkermes advanced after analyst upgrades shares on expected Risperdal Consta strength
Yahoo/AP
Fri, 12/19/08 - 10:26 am
Alkermes
Risperdal
JNJ
Eli Lilly
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11